0001070081-20-000013.txt : 20200108 0001070081-20-000013.hdr.sgml : 20200108 20200108180741 ACCESSION NUMBER: 0001070081-20-000013 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200106 FILED AS OF DATE: 20200108 DATE AS OF CHANGE: 20200108 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Utter Christine Marie CENTRAL INDEX KEY: 0001707685 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35969 FILM NUMBER: 20516671 MAIL ADDRESS: STREET 1: C/O PTC THERAPEUTICS, INC. STREET 2: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PTC THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001070081 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043416587 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080-2449 BUSINESS PHONE: 9082227000 MAIL ADDRESS: STREET 1: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080-2449 FORMER COMPANY: FORMER CONFORMED NAME: PTC THERAPEUTICS INC DATE OF NAME CHANGE: 19980909 4 1 wf-form4_157852483759758.xml FORM 4 X0306 4 2020-01-06 0 0001070081 PTC THERAPEUTICS, INC. PTCT 0001707685 Utter Christine Marie C/O PTC THERAPEUTICS, INC. 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080 0 1 0 0 SVP, Finance & CAO Common Stock 2020-01-06 4 S 0 360 48.168 D 5224 D Common Stock 2020-01-07 4 M 0 6250 13.10 A 11474 D Common Stock 2020-01-07 4 S 0 6250 50 D 5224 D Common Stock 2020-01-07 4 M 0 7500 18.01 A 12724 D Common Stock 2020-01-07 4 S 0 7500 50.031 D 5224 D Stock Option (Right To Buy) 13.1 2020-01-07 4 M 0 6250 13.10 D 2027-06-02 Common Stock 6250.0 0 D Stock Option (Right To Buy) 18.01 2020-01-07 4 M 0 7500 18.01 D 2028-01-02 Common Stock 7500.0 22500 D Stock Option (Right To Buy) 490.8 2021-04-27 Common Stock 74.0 74 D Stock Option (Right To Buy) 218.4 2022-01-10 Common Stock 21.0 21 D Stock Option (Right To Buy) 40.45 2024-09-23 Common Stock 4688.0 4688 D Stock Option (Right To Buy) 51.0 2025-01-02 Common Stock 17800.0 17800 D Stock Option (Right To Buy) 30.86 2026-01-03 Common Stock 10310.0 10310 D Stock Option (Right To Buy) 11.23 2027-01-02 Common Stock 3150.0 3150 D Stock Option (Right To Buy) 33.02 2029-01-21 Common Stock 42500.0 42500 D Stock Option (Right To Buy) 33.02 2029-01-21 Common Stock 10100.0 10100 D Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 975 RSUs from a January 3, 2017 grant of 3,900 RSUs. This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on November 29, 2019. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $50.00 to $50.09 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Currently exercisable. This option was granted on January 3, 2018, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2019, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2019. This option was granted on January 3, 2017, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2018, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2018. This option was granted on January 22, 2019 and vests over four years, with 25% of the shares underlying the option vesting on January 22, 2020, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning April 22, 2020. This option was granted on January 22, 2019 and vests over four years, with 50% of the shares underlying the option vesting on January 22, 2022, and the remaining 50% of the original number of shares underlying the option vesting on January 22, 2023. /s/ Avraham S. Adler, attorney-in-fact 2020-01-08